Relationship between cortical iron and tau aggregation in Alzheimer’s disease

Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology

(2019) Scott Ayton et al.   MOLECULAR PSYCHIATRY

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease

(2018) Marjolein Bulk et al.   NEUROBIOLOGY OF AGING

Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer’s Disease

(2018) Marjolein Bulk et al.   JOURNAL OF ALZHEIMERS DISEASE

Evaluation of18F-RO-948 (18F-RO6958948) for quantitative assessment of tau accumulation in the human brain with positron emission tomography

(2018) Hiroto Kuwabara et al.   JOURNAL OF NUCLEAR MEDICINE

A robust multi-scale approach to quantitative susceptibility mapping

(2018) Julio Acosta-Cabronero et al.   NEUROIMAGE

Quantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis

(2018) Julio Acosta-Cabronero et al.   RADIOLOGY

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

(2017) Anne Maass et al.   NEUROIMAGE

Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease

(2017) Hyug-Gi Kim et al.   NeuroImage-Clinical

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum

(2016) Hanna Cho et al.   ANNALS OF NEUROLOGY

The whole-brain pattern of magnetic susceptibility perturbations in Parkinson’s disease

(2016) Julio Acosta-Cabronero et al.   BRAIN

In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan

(2016) J. Acosta-Cabronero et al.   JOURNAL OF NEUROSCIENCE

High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R 2 * measurements at 7 T

(2016) Matthew J. Betts et al.   NEUROIMAGE

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment

(2016) J. M. G. van Bergen et al.   Scientific Reports

Tau positron emission tomographic imaging in aging and early Alzheimer disease

(2015) Keith A. Johnson et al.   ANNALS OF NEUROLOGY

Evidence of Redox-Active Iron Formation Following Aggregation of Ferrihydrite and the Alzheimer’s Disease Peptide β-Amyloid

(2014) James Everett et al.   INORGANIC CHEMISTRY

The role of iron in brain ageing and neurodegenerative disorders

(2014) Roberta J Ward et al.   LANCET NEUROLOGY

Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration

(2014) Scott Ayton et al.   Biomed Research International

Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry

(2013) Nikolaus Krebs et al.   JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY

In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease

(2013) Julio Acosta-Cabronero et al.   PLoS One

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

(2012) Scott J. Dixon et al.   CELL

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export

(2012) Peng Lei et al.   NATURE MEDICINE

Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study

(2012) Christian Langkammer et al.   NEUROIMAGE

The diagnosis of young-onset dementia

(2010) Martin N Rossor et al.   LANCET NEUROLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast

(2010) Masaki Fukunaga et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA